Safety and biomarker effects of solanezumab in patients with Alzheimer's disease

Martin Farlow, Steven E. Arnold, Christopher H. Van Dyck, Paul S. Aisen, B. Joy Snider, Anton P. Porsteinsson, Stuart Friedrich, Robert A. Dean, Celedon Gonzales, Gopalan Sethuraman, Ronald B. Demattos, Richard Mohs, Steven M. Paul, Eric R. Siemers